4
Changes in Ownership
Ultragenyx Pharmaceutical Inc. Filed Acc 0001209191-21-060748
See Remarks sold 358 shares at $81.14 ($29,048)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Pinion John Richard See Remarks | 2021-10-14 | Sale | −358 | $81.14 | $29,048 | 49,764 | D: show line 1 in the form |
| Open-market sales · 358 sh · avg $81.14 · $29,048 | |||||||
Loading xslF345X03/doc4.xml…